Arterial Hypertension, Diabetes Mellitus, Hypercholesterolemia
Conditions
Keywords
Diabetes mellitus
Brief summary
Project: An analysis of Diabetes Control in Puerto Rico Hypothesis: This project seeks to determine the causes for: i) poor adherence to prescribed treatment by patients, ii) low compliance by providers with national guidelines iii) barriers impose by health insurance in control of diabetes mellitus iv) effectiveness of a disease management program for treatment adherence by patients.
Detailed description
Method (s) The study will consist of three phases: i) assessment phase, ii) multimedia health education campaign for patients, providers and local health insurances for adherence improvement iii) reassessment phase. Target Population: Phase I: 600 Hispanic, male and female, residents of Puerto Rico with a diagnosis of type 1 and 2 diabetes mellitus older than 18 of age. Phase II: 600 patients identified in phase I with individualize health education interventions on the importance of adherence to prescribed medical treatment. 2) Spanish speaking population of Puerto Rico, health service providers, and health insurance companies through a multimedia health education campaign. Phase III: reassessment of the 600 patients of Phase I. Data Collection Tools: i) Demographic information will be obtained by an interview questionnaire. Patients will be assigned a control number automatically by the data system. ii) Laboratory blood samples for A1C, lipids (total cholesterol, triglycerides and HDL cholesterol), and serum creatinine. iii) A comprehensive educational adherence program with different media strategies such as: radio spots, newspaper articles, public service announcements, telemedicine services. Data Analysis: Data will be analyzed using SPSS for Windows.
Interventions
OTHEREpidemiological intervention
An analysis of 600 diabetic patients in the Island of PR to evaluate metabolic control.
Sponsors
Novo Nordisk A/S
Eli Lilly and Company
Center for Diabetes Control, Inc.
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Type 1 and 2 diabetic patients older tha 18 years old
Exclusion criteria
* 1\. Hemophilia. * 2\. Persons younger than 18. * 3\. Persons in research studies of some drug. * 4\. Persons using steroids. * 5\. Patients with acute infections. * 6\. Pregnant diabetic patients.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Lipids goal achievement | 2 years | The following lipids results will be considered out of goal for this population: LDL cholesterol greater than 100 mg/dL, HDL cholestero lower than 40 mg/dL in male and lower than 50 mg/dL in women, and serum triglycerides greater than 150 mg/dL |
| Blood sugar control | 2 years | Numbers of Patients with Hg A1C on control (less than 7%). Those with A1c greater than 7% will be considered as not meeting the goal |
| Blood pressure control | 2 years | Blood Pressure Control: Patients will be considered out of blood pressure control if they have a systolic blood pressure greater than 130 mm Hg or a diastolic blood pressure greater than 80 mg Hg |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Achievement of National Clinical Practice Recommendations among Puerto Rican Population with Diabetes Mellitus | 2 years | Type of therapies used by these populations and their relationship with out of goals outcome. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Achievement of National Clinical Practice Recommendations among Puerto Rican Population with Diabetes Mellitus | 1 year | Outcome measure assessment: Descriptive analysis will be computed to describe the demographic and health services characteristic of the participants. Bivariate analysis using contingency tables and the Pearson Chi-square test and independent samples t-tests will be conducted to determine whether or not there were differences between adults with diabetes and A1C levels lower than 7% and those with A1C levels greater than 7% in term of demographics, health services characteristics, health insurance type, type of providers, type of medication (insulin or pills) and comorbidities. For statistical analysis, alpha will be set at p \< 0.05. |
Outcome results
None listed